PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
18-Jan-2024 £13m disease early warning system for England to open at University of Bath Water-based community health monitoring Centre of Excellence
18-Jan-2024 Vetter becomes a member of the German Association of Research-Based Pharmaceutical Companies (vfa) Vetter
17-Jan-2024 Sahlgrenska Hospital invests in precision diagnostics with Qlucore Insights Qlucore
17-Jan-2024 Further Data Confirms POLB 001's Potential in Cancer Immunotherapy-Induced Cytokine Release Syndrome (CRS) Market opportunity estimated to be greater than US$1 billion Poolbeg Pharma plc
17-Jan-2024 Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research Discovery Park Ventures
16-Jan-2024 TrakCel launches Consultancy Services to share extensive cell and gene therapy process development expertise TrakCel
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Theriva Biologics to Participate in the B. Riley Securities Annual Oncology Conference Theriva Biologics, Inc
16-Jan-2024 CellQuest launches Early Access Program with first CosyNest automated CAR-T manufacturing partner CellQuest
16-Jan-2024 Phesi releases 2023 analysis of clinical development; breast cancer remains most studied disease area for third year Phesi
16-Jan-2024 DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform DelSiTech
16-Jan-2024 Calibre Scientific Acquires MoBiTec, a German Supplier of Research Tools for the Global Life Science, Diagnostic, and Pharmaceutical Industries Calibre Scientific
16-Jan-2024 Sterile Filtration Market Will Reach USD 19,111.3 Million By 2030 P&S Intelligence
15-Jan-2024 Strategic Insights into the Mass Spectrometry Market: Key Players and Market Dynamics Markets and Markets
12-Jan-2024 Evaluate announces acquisition of J+D Forecasting Evaluate
12-Jan-2024 Boehringer Ingelheim signs a two-year agreement with Qlucore Boehringer Ingelheim
12-Jan-2024 Leading Pharma Adopts Veeva Vault Validation Management for Digital Validation Execution and Improved Efficiency SK Life Science
10-Jan-2024 Pistoia Alliance Announces Dr Christian Baber as New Chief Portfolio Officer and Launches 2024 Project Pipeline The Pistoia Alliance
10-Jan-2024 Spago Nanomedical proceeds to the next dose level in the phase I/IIa study Tumorad-01 Spago Nanomedical AB (publ)
10-Jan-2024 Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma Ariceum Therapeutics